首页> 外文期刊>The Lancet >Current best practice for bladder cancer: a narrative review of diagnostics and treatments
【24h】

Current best practice for bladder cancer: a narrative review of diagnostics and treatments

机译:Current best practice for bladder cancer: a narrative review of diagnostics and treatments

获取原文
获取原文并翻译 | 示例
           

摘要

? 2022 Elsevier LtdThis Seminar presents the current best practice for the diagnosis and management of bladder cancer. The scope of this Seminar ranges from current challenges in pathology, such as the evolving histological and molecular classification of disease, to advances in personalised medicine and novel imaging approaches. We discuss the current role of radiotherapy, surgical management of non-muscle-invasive and muscle-invasive disease, highlight the challenges of treatment of metastatic bladder cancer, and discuss the latest developments in systemic therapy. This Seminar is intended to provide physicians with knowledge of current issues in bladder cancer.

著录项

  • 来源
    《The Lancet》 |2022年第10364期|1712-1721|共10页
  • 作者单位

    Department of Pathology and Laboratory Medicine and Urology University of Tennessee Health Science;

    Department of Pathology Tenon Hospital Sorbonne University;

    Department of Clinical Oncology The Christie NHS Foundation Trust and University of ManchesterDepartment of Urology Charité University HospitalDepartment of Urology The University of Texas MD Anderson Cancer CenterDepartment of Urology University HospitalDepartment of Radiology HFR Fribourg-H?pital Cantonal University of FribourgDepartment of Urology Radboud University Medical CenterDepartment of Oncology/Hematology Kantonsspital Graubünden;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 医药、卫生;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号